Group Testing with Homophily to Curb Epidemics with Asymptomatic Carriers - de Belleville, Louis-Marie Harpedanne (medRxiv, 2020)
Contagion happens through heterogeneous interpersonal relations (homophily) which induce contamination clusters. Group testing is increasingly recognized as necessary to fight the asymptomatic transmission of the COVID-19. Still, it is plagued by false negatives. Homophily can be taken into account to design test pools that encompass potential contamination clusters. I show that this makes it possible to overcome the usual information-theoretic limits of group testing, which are based on an implicit homogeneity assumption. Even more interestingly, a multiple-step testing strategy combining this approach with advanced complementary exams for all individuals in pools identified as positive identifies asymptomatic carriers who would be missed even by costly exhaustive individual tests. Recent advances in group testing have brought large gains in efficiency, but within the bounds of the above cited information-theoretic limits, and without tackling the false negatives issue which is crucial for COVID-19. Homophily has been considered in the contagion literature already, but not in order to improve group testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study has not benefited from any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study does not include any experiment: no IRB nor ethical committee approval was needed, no patient/participant consent was needed, and no institutional forms needed to be archivedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data: mathematical analysis